Cadila Healthcare buys US-based Sentynl Therapeutics
Sentynl's acquisition marks Cadila's foray into the $8 billion specialty pain management drug market in the US20-01-2017
20-01-2017
Zydus Cadila acquires Sentynl Therapeutics Inc., a US based specialty pharmaceutical company
Cadila Healthcare Ltd has submitted to BSE a copy of Press Release dated January 19, 2017 titled 'Zydus Cadila acquires Sentynl Therapeutics Inc., a US based specialty pharmaceutical company'20-01-2017
Post results Conference Call with investors/analysts
Cadila Healthcare Ltd has informed BSE regarding "Post results Conference Call with investors/analysts".19-01-2017
Zydus Cadila open for buyouts in the US
Denies reports of looking to acquire Sentynl Therapeutics19-01-2017
Cadila Healthcare Ltd reply to clarification sought by the exchange
The Exchange had sought clarification from Cadila Healthcare Ltd with respect to news appearing in Economic Times on January 18, 2017 titled "Cadila Set to Buy US Firm for $171 m."Cadila Healthcare Ltd response is enclosed.18-01-2017
Zydus receives final approval from the USFDA for Methotrexate Tablets USP
Cadila Healthcare Ltd has submitted to BSE a copy of Press Release dated January 18, 2017 titled ''Zydus receives final approval from the USFDA for Methotrexate Tablets USP".18-01-2017
Clarification sought from Cadila Healthcare Ltd
The Exchange has sought clarification from Cadila Healthcare Ltd with respect to news article appearing in Economic Times on January 18, 2017 titled "Cadila Set to Buy US Firm for $171 m."The reply is awaited.18-01-2017
Zydus announces settlement with Kowa Company, Ltd., Kowa Pharmaceuticals America, Inc. and Nissan Chemical Industries, Ltd. on Livalo (pitavastatin calcium) tablets
Cadila Healthcare Ltd has informed BSE regarding a Press Release dated January 17, 2017, titled "Zydus announces settlement with Kowa Company, Ltd., Kowa Pharmaceuticals America, Inc. and Nissan Chemical Industries, Ltd. on Livalo (pitavastatin calcium) tablets".17-01-2017
Cadila settles patent litigation related to anti-seizure drug
Pharmaceutical major Cadila Healthcare Ltd and its subsidiary Zydus Pharmaceuticals (USA) Inc., on Friday, announced that they have finalised an agreement with Upsher-Smith Laboratories, Inc. to...13-01-2017